Cholangiocarcinoma with a Background of Hepatitis B Virus-associated Cirrhosis

Internal Medicine

Volumn 40, Issue 5, 2001, Pages 382-385

  Takegoshi, Kunio ^a   Su, Qin ^b   Omata, Masao ^c   Taira, Sakae ^d   Okada, Eikichi ^e   Bannasch, Peter ^f  

^a Takegoshi Internal Medicine Clinic   (Japan)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF TOKYO   (Japan)

^d Takaoka City Hospital   (Japan)

^e UNIVERSITY OF TOYAMA   (Japan)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Hepatitis B virus; Immunohistochemistry; Liver cirrhosis; Viral protein

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CASE REPORT; FATALITY; HEPATITIS B; HUMAN; INTRAHEPATIC BILE DUCT; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; VIROLOGY;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FATAL OUTCOME; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 0035347578     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.382     Document Type: Article

References (24)

1. Anthony PP. Tumours and tumour-like lesions of the liver and biliary tract. in: Pathology of the Liver. 3rd ed. MacSween RNM, et al, Eds. Churchill Livingstone, Edinburgh, 1994: 635-711.
2. Ishak KG, Anthony PP, Sobin LH. Histological Typing of Tumours of the Liver. 2nd ed. WHO Series. Springer-Verlag, Berlin, 1994: 17-19.
3. Altaee MY, Johnson PJ, Farrant JM, Williams R. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer 68: 2051-2055, 1991.
4. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Ann Surg 211: 277-287, 1990.
5. Liver Cancer Study Group of Japan. Survey and follow-up study of primary liver cancer in Japan: Report 12. Kanzoh (Acta Heapatol Jap) 38: 317-330, 1997 (in Japanese, Abstract in English).
6. Liver Cancer Study Group of Japan. Survey and follow-up study of primary liver cancer in Japan: Report 13. Kanzoh (Acta Heapatol Jap) 40: 288-300, 1999 (in Japanese, Abstract in English).
7. Terada T, Kida T, Nakanuma Y, Kurumaya H, Doishita K, Takayanagi N. Intrahepatic cholangiocarcinomas associated with nonbiliary cirrhosis. J Clin Gastroenterol 18: 335-342, 1994.
8. Kaczynski J, Hansson G, Wallerstedt S. Incidence, etiologic aspects and clinicopathologic features in intrahepatic cholangiocellular carcinoma: A study of 51 cases from a low-endemicity area. Acta Oncol 37: 77-83, 1998.
9. Tomimatsu M, Ishiguro N, Taniai M, Okuda H, Saito A, Obata H, et al. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan. Cancer 72: 683-688, 1993.
10. Yamamoto M, Takasaki K, Nakano M, Saito A. Minute nodular intrahepatic cholangiocarcinoma. Cancer 82: 2145-2149, 1998.
11. Nagaoka T, Ohkawa S, Ito Y, Tamai S, Tarao K, Sugimasa Y, et al. A case of minute cholangiocellular carcinoma which was found in the follow-up periods of the liver cirrhosis and was indistinguishable from hepatocellular carcinoma on hepatic angiography. Nippon Shokakibyo Gakkai Zasshi (Jap J Gastroenterol) 88: 1369-1374, 1991 (in Japanese, Abstruct in English).
12. Yokoyama T, Yhata N, Ootani H, Asahara T, Dohi K, Yamamoto M. A case of small cholangiocellular carcinoma occurring 12 years after resection of hepatocellular carcinoma associated with B viral cirrhosis. Kanzoh (Acta Heapatol Jap) 34: 753-757, 1993 (in Japanese, Abstract in English).
13. Imsamran W, Ratanachu-ek T. Preoperative portal vein embolization in major hepatectomy for hilar cholangiocarcinoma: A case report. J Med Assoc Thai 81: 627-632, 1998.
14. Geissler M, Gesien A, Wands JR. Molecular mechanisms of hepatocarcinogenesis. in: Liver Cancer. Okuda K, Tabor E, Eds. Churchill Livingstone, New York, 1997: 59-88.
15. Wang W, London WT, Feitelson MA. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res 51: 4971-4977, 1991.
16. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled (PAP) procedures. J Histochem Cytochem 29: 577-580, 1981.
17. Su Q, Schröder CH, Hofmann WJ, Otto G, Pichlmatr R, Bannasch P. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepalology 27: 1109-1120, 1998.
18. Bisceglie AMD. Malignant neoplasm of the liver. in: Schiff's Diseases of the Liver. Eighth ed. Lippincott-Raven, New York, 1999: 1281-1304.
19. Su Q, Lie YF, Zhang JF, Zhang SX, Li DF, Yang JJ. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: Its relationship with hepatitis B virus antigen expression. Hepatology 20: 788-799, 1994.
20. Zentgraf H, Herrmann G, Klein R, et al. Mouse monoclonal antibody directed against hepatitis B virus X protein synthesized in Escherichia coli: Detection of reactive antigen in liver cell carcinoma and chronic hepatitis. Oncology 47: 143-148, 1990.
21. Haruna Y, Hayashi N, Katayama K, et al. Expression of X protein and hepatitis B virus replication in chronic hepatitis. Hepatology 13: 417-421, 1991.
22. Blum HE, Stowring L, Figus A, Montgomery CK, Haase AT, Vyas GN. Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. Proc Natl Acad Sci 80: 6685-6688, 1983.
23. Nicoll AJ, Angus PW, Ghou ST, Luscombe CA, Smallwood RA, Locarnini SA. Demonstration of duck hepatitis B virus in bile duct epithelial cells: Implications for pathogenesis and persistent infection. Hepatology 25: 463-469, 1997.
24. Bannasch P, Zerban H. Cholangiofibroma and cholangiocarcinoma, liver, rat. in: Digestive System. 2nd ed. Jones TC, Popp JA, Mohr U, Eds. Springer, Berlin, Heidelberg, New York, 1997: 63-82.